Donovan, Lois E. http://orcid.org/0000-0001-8911-8192
Bell, Rhonda C. http://orcid.org/0000-0002-4298-9641
Feig, Denice S.
Lemieux, Patricia http://orcid.org/0000-0003-4448-9437
Murphy, Helen R.
Sigal, Ronald J.
Ho, Josephine http://orcid.org/0000-0003-0379-4427
Virtanen, Heidi
Crawford, Susan
Yamamoto, Jennifer M.
Funding for this research was provided by:
Calgary Health Trust
Article History
Received: 28 February 2024
Accepted: 4 June 2024
First Online: 19 July 2024
Acknowledgements
: The authors thank those that participated in this research, as well as research staff, including C. Oldford and C. S. Young (both University of Calgary, Calgary, AB, Canada), A. Galper (Lunenfeld-Tanenbaum Research Institute, and Sinai Health System, Mount Sinai Hospital, Toronto, ON, Canada), M.-C. Dubé (Laval University, Quebec City, QC, Canada) and M. Chrisp (University of Manitoba, Winnipeg, MB, Canada). We also thank B. Toppings (Toppings Engineering, Calgary, AB, Canada) for support with figure preparation.
: Study data are available from the corresponding author by request after ethics review and approval for the proposed study is provided and approved by the CLIMB steering committee.
: The Calgary Health Trust funded this study (there is no grant number for this). Medtronic provided in-kind support of Guardian Link 3 transmitters and Guardian Sensor (3) sensors, and the loan of study devices, MiniMed 670G and 770G insulin pumps and transmitter docks. The funders of the study had no role in the study design, data collection, data analysis, or data interpretation.
: LED reports in-kind donations and reduced cost for study supplies for investigator-initiated trials from Medtronic, Dexcom, Tandem Diabetes Care and Inter-analytics. JMY reports in-kind donations and reduced cost for study supplies for investigator-initiated trials from Medtronic and Abbott. DSF reports in-kind donations for study supplies for investigator-initiated trials from Medtronic, Dexcom, Tandem Diabetes Care and Inter-analytics, is on the Advisory Board for Ypsomed and reports honoraria from Sanofi and Novo Nordisk. HRM sits on the Medtronic European Scientific Advisory Board and reports receiving speaker honoraria from Dexcom, Abbott, Medtronic and Novo Nordisk, and is a member of the Editorial Board of <i>Diabetologia</i>. RJS reports research support from Novo Nordisk. PL reports speaker fees from Dexcom. All other authors declare that there are no relationships or activities that might bias, or be perceived to bias, their work.
: LED, JMY, RJS and RCB designed the study protocol. LED, DSF, PL and JMY enrolled participants and provided clinical care to participants enrolled at their respective institutions. JH advised on infant outcomes. All authors contributed to the statistical analysis plan. LED oversaw the conduct of the trial. LED wrote the first draft of the manuscript. All authors reviewed and provided critical revisions to the manuscript. All authors approved the final version of the manuscript to be published. LED and SC are the guarantors of this work and, as such, had full access to all the data and take responsibility for the integrity of the data and the accuracy of the data analysis.